Patent ID: 7504223

Claim:
A method of determining a survival probability of a first patient with breast cancer, comprising (a) assaying the level of annexin VII (ANX7) protein expression in a tissue sample from the first patient's breast, (b) comparing the level of ANX7 protein expression in the tissue sample to the ANX7 protein expression level in an ANX7 expression level-survival matrix, wherein the ANX7 expression level-survival matrix is obtained by determining the levels of ANX7 protein expression in breast tissue samples of patients diagnosed with breast cancer other than the first patient, categorizing the levels of ANX7 protein expression, and correlating each ANX7 protein expression level with known survival of the patients diagnosed with breast cancer, (c) determining the category level of ANX7 protein expression of the first patient from the ANX7 expression level-survival matrix, and (d) determining the survival probability of the first patient.